TEST BANK w#
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
w# w# w# w# w# w# w#
Author: Teri Moser Woo and Wendy L. Wright
w# w# w# w# w# w# w#
, TABLE OF CONTENT w# w#
Chapter w# 1.
w# The Role of the Advanced Practice Nurse as Prescriber ............................................................... 4
w# w# w# w# w# w# w# w#
Chapter w# 2. w#Review of Basic Principles of Pharmacology ................................................................................. 5
w# w# w# w# w#
Chapter w# 3.w# Rational Drug Selection .................................................................................................................. 11
w# w#
Chapter w# 4.w# Legal and Professional Issues in Prescribing ................................................................................ 14
w# w# w# w# w#
Chapter w# 5.w# Adverse Drug Reactions ................................................................................................................. 16
w# w#
Chapter w# 6.w# An Introduction to Pharmacogenomics .......................................................................................... 19
w# w# w#
Chapter w# 7. w#Nutrition and Nutraceuticals ........................................................................................................... 22
w# w#
Chapter w# 8.w# Herbal Therapies .............................................................................................................................. 28
w#
Chapter w# 9. w#Cannabis ........................................................................................................................................... 31
Chapter 10.
w# w# Pharmacoeconomics ....................................................................................................................... 35
Chapter 11.
w# w# Drugs Affecting the Autonomic Nervous System....................................................................... 38
w# w# w# w# w#
Chapter 12.
w# w# Drugs Affecting the Central Nervous System ............................................................................. 45
w# w# w# w# w#
Chapter 13.
w# w# Drugs Affecting the Cardiovascular and Renal Systems ............................................................ 53
w# w# w# w# w# w#
Chapter 14.
w# w# Drugs Affecting the Respiratory System ..................................................................................... 61
w# w# w# w#
Chapter 15.
w# w# Drugs Affecting the Hematological System ................................................................................ 65
w# w# w# w#
Chapter 16.
w# w# Drugs Affecting the Immune System: Vaccines and Immunoglobulins .................................... 69
w# w# w# w# w# w# w#
Chapter 17.
w# w# Drugs Affecting the Immune System: Immunomodulators......................................................... 75
w# w# w# w# w#
Chapter 18.
w# w# Drugs Affecting the Gastrointestinal System............................................................................... 77
w# w# w# w#
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ............ 80
w# w# w# w# w# w# w# w# w# w# w#
Chapter 20.
w# w# Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ..................... 83
w# w# w# w# w# w# w# w# w#
Chapter 21.
w# w# Drugs Affecting the Reproductive System .................................................................................. 86
w# w# w# w#
Chapter 22.
w# w# Drugs Affecting the Bones and Joints ......................................................................................... 92
w# w# w# w# w#
Chapter 23.
w# w# Drugs Affecting the Integumentary System................................................................................. 96
w# w# w# w#
Chapter 24.
w# w# Drugs Used to Treat Bacterial Infections .................................................................................. 101
w# w# w# w# w#
Chapter 25.
w# w# Drugs Used to Treat Viral, Fungal, and Protozoal Infections ................................................. 105
w# w# w# w# w# w# w# w#
Chapter 26.
w# w# Drugs Used to Treat Inflammatory Processes ........................................................................... 108
w# w# w# w# w#
Chapter 27.
w# w# Drugs Used to Treat Eye and Ear Disorders ............................................................................ 111
w# w# w# w# w# w# w#
Chapter 28.
w# w# Anemia ......................................................................................................................................... 113
Chapter 29.
w# w# Anxiety and Depression .............................................................................................................. 116
w# w#
Chapter 30.
w# w# Attention Deficit-Hyperactivity Disorder ................................................................................... 120
w# w#
Chapter 31.
w# w# Asthma and Allergy .................................................................................................................... 122
w# w#
Chapter 32.
w# w# Chronic Obstructive Pulmonary Disease .................................................................................... 125
w# w# w#
Chapter 33.
w# w# Contraception ............................................................................................................................... 127
Chapter 34.
w# w# COVID-19: Acute and Chronic .................................................................................................. 130
w# w# w#
Chapter 35.
w# w# Dermatological Conditions .......................................................................................................... 134
w#
Chapter 36.
w# w# Diabetes Management.................................................................................................................. 138
w#
Chapter 37.
w# w# Gastroesophageal Reflux and Peptic Ulcer Disease.................................................................. 146
w# w# w# w# w#
Chapter 38.
w# w# Headaches ..................................................................................................................................... 149
Chapter 39. Heart Failure ................................................................................................................................ 153
w# w# w#
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ....................................................... 158
w# w# w# w# w# w# w#
Chapter 41. Menopausal Hormone Therapy ................................................................................................... 161
w# w# w# w#
,Chapter 42. Hyperlipidemia ............................................................................................................................. 164
w# w#
Chapter 43. Hypertension................................................................................................................................. 169
w# w#
Chapter 44. Hyperthyroidism and Hypothyroidism........................................................................................ 174
w# w# w# w#
Chapter 45. Obesity ......................................................................................................................................... 177
w# w#
Chapter 46. Pain Management: Acute and Chronic Pain.............................................................................. 181
w# w# w# w# w# w# w#
Chapter 47. Pneumonia .................................................................................................................................... 185
w# w#
Chapter 48. Sexually Transmitted Diseases and Vaginitis ............................................................................ 187
w# w# w# w# w# w#
Chapter 49. Substance Use Disorders ............................................................................................................. 190
w# w# w# w#
Chapter 50. Tuberculosis ................................................................................................................................. 195
w# w#
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa .. 197
w# w# w# w# w# w# w# w# w# w# w# w#
Chapter 52. Urinary Tract Infections .............................................................................................................. 200
w# w# w# w#
Chapter 53. Women as Patients ...................................................................................................................... 203
w# w# w# w#
Chapter 54. Men as Patients ........................................................................................................................... 207
w# w# w# w#
Chapter 55. Pediatric Patients.......................................................................................................................... 209
w# w# w#
Chapter 57. Geriatric Patients.......................................................................................................................... 213
w# w# w#
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6 w# w# w# w# Ch01
e
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
w# w# w# w# w# w# w# w# w# w#
MULTIPLE CHOICE
w#
1. Nurse practitioner prescriptive authority is regulated by:
w# w# w# w# w# w#
A. The National Council of State Boards of Nursing
w# w# w# w# w# w# w#
B. The U.S. Drug Enforcement Administration
w# w# w# w#
C. The State Board of Nursing for each state
w# w# w# w# w# w# w#
D. The State Board of Pharmacy
w# w# w# w#
ANS: w # C PTS: w # w # 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescr
w# w# w# w# w# w# w# w# w# w# w# w# w#
iber include:
w#
A. Nurses know more about pharmacology than other prescribers because they tak
w# w# w# w# w# w# w# w# w# w#
e it both in their basic nursing program and in their APRN program.
w# w# w# w# w# w# w# w# w# w# w# w#
B. Nurses care for the patient from a holistic approach and include the patie
w# w# w# w# w# w# w# w# w# w# w# w#
nt in decision-making regarding their care.
w# w# w# w# w#
C. APRNs are less likely to prescribe narcotics and other controlled substances.
w# w# w# w# w# w# w# w# w# w#
D. APRNs are able to prescribe independently in all states, whereas a physicia
w# w# w# w# w# w# w# w# w# w# w#
n’s assistant needs to have a physician supervising their practice.
w# w# w# w# w# w# w# w# w#
ANS: w # B PTS: w # w # 1
3. Clinical judgment in prescribing includes:
w# w# w# w#
A. Factoring in the cost to the patient of the medication prescribed
w# w# w# w# w# w# w# w# w# w#
B. Always prescribing the newest medication available for the disease process
w# w# w# w# w# w# w# w# w#
C. Handing out drug samples to poor patients
w# w# w# w# w# w#
D. Prescribing all generic medications to cut costs
w# w# w# w# w# w#
ANS: w # A PTS: w # w # 1
4. The process for choosing an effective drug for a disorder includes:
w# w# w# w# w# w# w# w# w# w#
A. Asking the patient what drug they think would work best for them
w# w# w# w# w# w# w# w# w# w# w#
B. Consulting nationally recognized guidelines for disease management
w# w# w# w# w# w#
C. Prescribing medications that are available as samples before writing a prescription
w# w# w# w# w# w# w# w# w# w#
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
w# w# w# w# w# w# w#
ANS: w # B PTS: w # w # 1
5. Nonintentional nonadherence of drug therapy may occur due to:
w# w# w# w# w# w# w# w#
A. Belief that medication does not work
w# w# w# w# w#
B. Adverse drug reactions w# w#
C. Chronic conditions that require daily therapy
w# w# w# w# w#
D. Forgetfulness or distraction w# w#
ANS: w # D PTS: w # w # 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
w# w# w# w# w# w# w#
Author: Teri Moser Woo and Wendy L. Wright
w# w# w# w# w# w# w#
, TABLE OF CONTENT w# w#
Chapter w# 1.
w# The Role of the Advanced Practice Nurse as Prescriber ............................................................... 4
w# w# w# w# w# w# w# w#
Chapter w# 2. w#Review of Basic Principles of Pharmacology ................................................................................. 5
w# w# w# w# w#
Chapter w# 3.w# Rational Drug Selection .................................................................................................................. 11
w# w#
Chapter w# 4.w# Legal and Professional Issues in Prescribing ................................................................................ 14
w# w# w# w# w#
Chapter w# 5.w# Adverse Drug Reactions ................................................................................................................. 16
w# w#
Chapter w# 6.w# An Introduction to Pharmacogenomics .......................................................................................... 19
w# w# w#
Chapter w# 7. w#Nutrition and Nutraceuticals ........................................................................................................... 22
w# w#
Chapter w# 8.w# Herbal Therapies .............................................................................................................................. 28
w#
Chapter w# 9. w#Cannabis ........................................................................................................................................... 31
Chapter 10.
w# w# Pharmacoeconomics ....................................................................................................................... 35
Chapter 11.
w# w# Drugs Affecting the Autonomic Nervous System....................................................................... 38
w# w# w# w# w#
Chapter 12.
w# w# Drugs Affecting the Central Nervous System ............................................................................. 45
w# w# w# w# w#
Chapter 13.
w# w# Drugs Affecting the Cardiovascular and Renal Systems ............................................................ 53
w# w# w# w# w# w#
Chapter 14.
w# w# Drugs Affecting the Respiratory System ..................................................................................... 61
w# w# w# w#
Chapter 15.
w# w# Drugs Affecting the Hematological System ................................................................................ 65
w# w# w# w#
Chapter 16.
w# w# Drugs Affecting the Immune System: Vaccines and Immunoglobulins .................................... 69
w# w# w# w# w# w# w#
Chapter 17.
w# w# Drugs Affecting the Immune System: Immunomodulators......................................................... 75
w# w# w# w# w#
Chapter 18.
w# w# Drugs Affecting the Gastrointestinal System............................................................................... 77
w# w# w# w#
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ............ 80
w# w# w# w# w# w# w# w# w# w# w#
Chapter 20.
w# w# Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ..................... 83
w# w# w# w# w# w# w# w# w#
Chapter 21.
w# w# Drugs Affecting the Reproductive System .................................................................................. 86
w# w# w# w#
Chapter 22.
w# w# Drugs Affecting the Bones and Joints ......................................................................................... 92
w# w# w# w# w#
Chapter 23.
w# w# Drugs Affecting the Integumentary System................................................................................. 96
w# w# w# w#
Chapter 24.
w# w# Drugs Used to Treat Bacterial Infections .................................................................................. 101
w# w# w# w# w#
Chapter 25.
w# w# Drugs Used to Treat Viral, Fungal, and Protozoal Infections ................................................. 105
w# w# w# w# w# w# w# w#
Chapter 26.
w# w# Drugs Used to Treat Inflammatory Processes ........................................................................... 108
w# w# w# w# w#
Chapter 27.
w# w# Drugs Used to Treat Eye and Ear Disorders ............................................................................ 111
w# w# w# w# w# w# w#
Chapter 28.
w# w# Anemia ......................................................................................................................................... 113
Chapter 29.
w# w# Anxiety and Depression .............................................................................................................. 116
w# w#
Chapter 30.
w# w# Attention Deficit-Hyperactivity Disorder ................................................................................... 120
w# w#
Chapter 31.
w# w# Asthma and Allergy .................................................................................................................... 122
w# w#
Chapter 32.
w# w# Chronic Obstructive Pulmonary Disease .................................................................................... 125
w# w# w#
Chapter 33.
w# w# Contraception ............................................................................................................................... 127
Chapter 34.
w# w# COVID-19: Acute and Chronic .................................................................................................. 130
w# w# w#
Chapter 35.
w# w# Dermatological Conditions .......................................................................................................... 134
w#
Chapter 36.
w# w# Diabetes Management.................................................................................................................. 138
w#
Chapter 37.
w# w# Gastroesophageal Reflux and Peptic Ulcer Disease.................................................................. 146
w# w# w# w# w#
Chapter 38.
w# w# Headaches ..................................................................................................................................... 149
Chapter 39. Heart Failure ................................................................................................................................ 153
w# w# w#
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ....................................................... 158
w# w# w# w# w# w# w#
Chapter 41. Menopausal Hormone Therapy ................................................................................................... 161
w# w# w# w#
,Chapter 42. Hyperlipidemia ............................................................................................................................. 164
w# w#
Chapter 43. Hypertension................................................................................................................................. 169
w# w#
Chapter 44. Hyperthyroidism and Hypothyroidism........................................................................................ 174
w# w# w# w#
Chapter 45. Obesity ......................................................................................................................................... 177
w# w#
Chapter 46. Pain Management: Acute and Chronic Pain.............................................................................. 181
w# w# w# w# w# w# w#
Chapter 47. Pneumonia .................................................................................................................................... 185
w# w#
Chapter 48. Sexually Transmitted Diseases and Vaginitis ............................................................................ 187
w# w# w# w# w# w#
Chapter 49. Substance Use Disorders ............................................................................................................. 190
w# w# w# w#
Chapter 50. Tuberculosis ................................................................................................................................. 195
w# w#
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa .. 197
w# w# w# w# w# w# w# w# w# w# w# w#
Chapter 52. Urinary Tract Infections .............................................................................................................. 200
w# w# w# w#
Chapter 53. Women as Patients ...................................................................................................................... 203
w# w# w# w#
Chapter 54. Men as Patients ........................................................................................................................... 207
w# w# w# w#
Chapter 55. Pediatric Patients.......................................................................................................................... 209
w# w# w#
Chapter 57. Geriatric Patients.......................................................................................................................... 213
w# w# w#
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6 w# w# w# w# Ch01
e
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
w# w# w# w# w# w# w# w# w# w#
MULTIPLE CHOICE
w#
1. Nurse practitioner prescriptive authority is regulated by:
w# w# w# w# w# w#
A. The National Council of State Boards of Nursing
w# w# w# w# w# w# w#
B. The U.S. Drug Enforcement Administration
w# w# w# w#
C. The State Board of Nursing for each state
w# w# w# w# w# w# w#
D. The State Board of Pharmacy
w# w# w# w#
ANS: w # C PTS: w # w # 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescr
w# w# w# w# w# w# w# w# w# w# w# w# w#
iber include:
w#
A. Nurses know more about pharmacology than other prescribers because they tak
w# w# w# w# w# w# w# w# w# w#
e it both in their basic nursing program and in their APRN program.
w# w# w# w# w# w# w# w# w# w# w# w#
B. Nurses care for the patient from a holistic approach and include the patie
w# w# w# w# w# w# w# w# w# w# w# w#
nt in decision-making regarding their care.
w# w# w# w# w#
C. APRNs are less likely to prescribe narcotics and other controlled substances.
w# w# w# w# w# w# w# w# w# w#
D. APRNs are able to prescribe independently in all states, whereas a physicia
w# w# w# w# w# w# w# w# w# w# w#
n’s assistant needs to have a physician supervising their practice.
w# w# w# w# w# w# w# w# w#
ANS: w # B PTS: w # w # 1
3. Clinical judgment in prescribing includes:
w# w# w# w#
A. Factoring in the cost to the patient of the medication prescribed
w# w# w# w# w# w# w# w# w# w#
B. Always prescribing the newest medication available for the disease process
w# w# w# w# w# w# w# w# w#
C. Handing out drug samples to poor patients
w# w# w# w# w# w#
D. Prescribing all generic medications to cut costs
w# w# w# w# w# w#
ANS: w # A PTS: w # w # 1
4. The process for choosing an effective drug for a disorder includes:
w# w# w# w# w# w# w# w# w# w#
A. Asking the patient what drug they think would work best for them
w# w# w# w# w# w# w# w# w# w# w#
B. Consulting nationally recognized guidelines for disease management
w# w# w# w# w# w#
C. Prescribing medications that are available as samples before writing a prescription
w# w# w# w# w# w# w# w# w# w#
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
w# w# w# w# w# w# w#
ANS: w # B PTS: w # w # 1
5. Nonintentional nonadherence of drug therapy may occur due to:
w# w# w# w# w# w# w# w#
A. Belief that medication does not work
w# w# w# w# w#
B. Adverse drug reactions w# w#
C. Chronic conditions that require daily therapy
w# w# w# w# w#
D. Forgetfulness or distraction w# w#
ANS: w # D PTS: w # w # 1
